Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Contract Wins

12 Jun 2024 07:00

RNS Number : 0440S
Checkit PLC
12 June 2024
 

12 June 2024

 

Checkit plc

("Checkit" or the "Group")

 

Contract Wins

 

Checkit (AIM: CKT), the automated monitoring platform for operational leaders, is pleased to announce a significant expansion with an existing US customer and a first customer for the recently launched AI module.

 

Contract Wins

 

The Group announces a significant expansion with Octaphama Plasma in the United States worth c.£718,000 over three years.

 

Octapharma will be expanding their use of the Checkit platform by integrating TTMUs (Tactical Temperature Monitoring Units) into their existing monitoring system, further protecting their operational data and mission-critical inventory. By leveraging the TTMUs offline data logging capabilities, Octapharma will have complete data redundancy across their entire network of plasma donation centres in the US. The investment highlights Octapharma's ongoing commitment to ensuring the safety and security of their plasma and operational data.

 

The Group is also pleased to announce a first signed contract for the recently launched Asset Intelligence product module, which applies advanced analytics and Machine Learning to IoT data which will help enhance customer sustainability, reduce costs, and improve revenue.

 

Commenting on the news Kit Kyte, Chief Executive Officer, said: "This latest win continues to validate our 'land and expand' strategy and demonstrates continued momentum in the US, a strategic priority for the business. Forward-thinking leaders like Octapharma understand why it's so critical to execute an operational data strategy, and we appreciate their trust and partnership. I am also thrilled that we have secured our first customer for the recently launched Asset Intelligence module, which marks the start of an exciting chapter in the evolution of our offering and our integrated end-to-end platform."

 

For further information, please visit www.checkit.net or contact:

 

Checkit plc

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial and Operations Officer)

+44 (0) 1223 643313

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / Peter Steel / James Fischer

+44 (0) 20 7496 3000

Tavistock (Financial PR)

Lulu Bridges / Katie Hopkins / Simon Hudson

+44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFITRLILLIS
Date   Source Headline
2nd Dec 202111:00 amRNSHolding(s) in Company
2nd Dec 202111:00 amRNSHolding(s) in Company
29th Nov 202111:44 amRNSPosting of Circular and Notice of General Meeting
26th Nov 20212:23 pmRNSResult of Placing
26th Nov 20217:00 amRNSProposed Placing
28th Oct 20217:00 amRNSContract win
16th Sep 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20213:13 pmRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSProduct Update
13th Jul 20215:08 pmRNSGrant of options and PDMR dealings
12th Jul 20217:00 amRNSAppointment of Chief Executive Officer
29th Jun 20214:01 pmRNSCapital Markets Day
10th Jun 20219:16 amRNSPDMR Dealing
7th Jun 20217:00 amRNSAppointment of Non-Executive Director
3rd Jun 202112:25 pmRNSResult of AGM
13th May 20217:00 amRNSTrading Update
10th May 202112:23 pmRNSPosting of Annual Report and Notice of AGM
4th May 20214:02 pmRNSDirector Dealing
29th Apr 202110:00 amRNSBoard Changes
29th Apr 20217:00 amRNSPreliminary Results
21st Apr 20217:00 amRNSProduct update announcement
23rd Mar 20213:54 pmRNSHolding(s) in Company
22nd Mar 202112:33 pmRNSHolding(s) in Company
19th Mar 20217:00 amRNSElectronic Communications
22nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Feb 20217:00 amRNSGrant of options and PDMR dealings
11th Feb 20217:00 amRNSTrading Update
4th Feb 20217:00 amRNSAcquisition and Business Development Appointments
21st Dec 20205:14 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSDirector Dealing, Exercise of Options and TVR
2nd Dec 20207:00 amEQSCheckit (CKT): Initiation - Smarter operations management
2nd Dec 20207:00 amRNSEdison Investment Research Initiates Coverage
1st Dec 20202:30 pmEQSCheckit (CKT): Initiation - Smarter operations management
10th Nov 20207:00 amRNSTrading Update
19th Oct 20207:00 amRNSContract with John Lewis
24th Sep 20207:00 amRNSBoard Changes
21st Sep 20204:27 pmRNSPDMR Dealing
16th Sep 20207:00 amRNSHalf Year Results
12th Aug 20207:00 amRNSTrading update and notice of interim results
6th Aug 20207:00 amRNSBoard Changes
31st Jul 20201:54 pmRNSResult of AGM
9th Jul 20203:38 pmRNSPDMR Dealing
7th Jul 202010:34 amRNSGrant of share options and PDMR dealings
7th Jul 20207:38 amRNSPosting of Annual Report and Notice of AGM
6th Jul 20207:00 amRNSAppointment of CFO designate
1st Jul 202012:40 pmRNSDisposal of assets
16th Jun 20207:00 amRNSPreliminary Results
2nd Jun 20204:15 pmRNSChange to AGM date and arrangements
26th May 20207:00 amRNSCOVID-19 Update and Change to Results Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.